Prolymphocytic Leukemia Overview

Save information for later
Sign Up

Learn About Prolymphocytic Leukemia

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Prolymphocytic Leukemia Local Doctors?
Elite in Prolymphocytic Leukemia
Hematology | Oncology
Elite in Prolymphocytic Leukemia
Hematology | Oncology

MD Anderson

2130 W Holcombe Blvd, Univ Of Tx M D Ande Life, 
Houston, TX 
Languages Spoken:
English
Offers Telehealth

Tapan Kadia is a Hematologist and an Oncologist in Houston, Texas. Dr. Kadia is rated as an Elite provider by MediFind in the treatment of Prolymphocytic Leukemia. His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.

Michael J. Hallek
Elite in Prolymphocytic Leukemia
Elite in Prolymphocytic Leukemia
Kerpener Street 62, 
Koeln, NW, DE 

Michael Hallek practices in Koeln, Germany. Mr. Hallek is rated as an Elite expert by MediFind in the treatment of Prolymphocytic Leukemia. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Leukemia, Prolymphocytic Leukemia, and Bone Marrow Transplant.

 
 
 
 
Learn about our expert tiers
Learn More
Stephan Stilgenbauer
Elite in Prolymphocytic Leukemia
Elite in Prolymphocytic Leukemia
Albert Einstein Allee 23, 
Ulm, BW, DE 

Stephan Stilgenbauer practices in Ulm, Germany. Mr. Stilgenbauer is rated as an Elite expert by MediFind in the treatment of Prolymphocytic Leukemia. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Leukemia, Small Lymphocytic Lymphoma (SLL), and Bone Marrow Transplant.

What are the latest Prolymphocytic Leukemia Clinical Trials?
Phase I Multicenter Study of Ruxolitinib and Duvelisib in Relapsed or Refractory T- or NK-Cell Lymphomas

Summary: This study will test the safety of ruxolitinib, given at one dose that does not change, and duvelisib, given at different doses, to find out what effects, if any, the study treatment has on people with relapsed or refractory NK-cell or T-cell lymphoma. This study has three parts: dose escalation (Part 1), dose expansion (Part 2), and TFH/T-PLL cohort expansion (Part 3).

Match to trials
Find the right clinical trials for you in under a minute
Get started
Hematopoietic Stem Cell Transplantation From Haploidentical Donors in Patients With Hematological Malignancies Using a Treosulfan-Based Preparative Regimen

Summary: This phase II trial studies how well a donor stem cell transplant, treosulfan, fludarabine, and total-body irradiation work in treating patients with blood cancers (hematological malignancies). Giving chemotherapy and total-body irradiation before a donor stem cell transplant helps stop the growth of cells in the bone marrow, including normal blood-forming cells (stem cells) and cancer cells. It m...